Annual report pursuant to Section 13 and 15(d)

Schedule of Components of Assets and Liabilities and Revenue Classified as Discontinued Operations (Details)

v3.23.1
Schedule of Components of Assets and Liabilities and Revenue Classified as Discontinued Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Current assets of discontinued operations $ 3,093
Current liabilities of discontinued operations 858 3,157
Revenue, net 5,678 8,197
Loss from discontinued operations (15,968) (7,671)
Gain (loss) on sale of Pharma Solutions
Income tax expense 125 235
Loss from discontinued operations, net of tax (16,093) (7,906)
Discontinued Operations, Disposed of by Sale [Member]    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Accounts receivable, net 1,486
Other 1,607
Current assets of discontinued operations 3,093
Property and equipment, net 6,032
Other intangible assets, net 5,155
Goodwill 8,433
Other 2,767
Long-term assets of discontinued operations 22,387
Total assets 25,480
Accounts payable 1,320
Accrued salary and bonus 92 335
Other [1] 766 1,502
Current liabilities of discontinued operations 858 3,157
Operating lease liabilities, net of current portion 2,634
Other 71
Long-term liabilities of discontinued operations 2,705
Total liabilities $ 858 $ 5,862
[1] Includes $766 of liabilities related to the former Commercial Services business unit.